2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Aphios: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction APH-1501, Placebo - Addiction, Opioid Dependence | Phase 2 | Unknown | Aphios | 32 | 2023-10-01 | 2021-07-27 |
| Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease APH-1105, Placebo - Dementia, Alzheimer Disease 1 | Phase 2 | Unknown | Aphios | 60 | 2023-06-01 | 2021-07-27 |
Alzheimer Disease (1) · Alzheimer disease type 1 (1) · Alzheimer disease type 2 (1) · Alzheimer disease, familial, type 3 (1) · Behavior, Addictive (1) · Dementia (1) · Marijuana Abuse (1) · Mental Disorders (1) · Opioid-Related Disorders (1) · Substance-Related Disorders (1)